dasatinib dr.reddy's dasatinib 70 mg film coated tablet blister pack
dr reddys laboratories australia pty ltd - dasatinib propylene glycol, quantity: 81.2 mg (equivalent: dasatinib, qty 70 mg) - tablet, film coated - excipient ingredients: silicon dioxide; croscarmellose sodium; magnesium stearate; triacetin; titanium dioxide; microcrystalline cellulose; lactose; hydrogenated castor oil; hypromellose - dasatinib dr.reddy's is indicated for the treatment of adults aged 18 years or over with: ? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase. ? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib. ? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy. ? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib dr.reddy's is indicated for the treatment of paediatric patients with: ? ph+ cml in the chronic phase. ? newly diagnosed ph+ all in combination with chemotherapy.
dasatinib dr.reddy's dasatinib 50 mg film coated tablet blister pack
dr reddys laboratories australia pty ltd - dasatinib propylene glycol, quantity: 58 mg (equivalent: dasatinib, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; hydrogenated castor oil; magnesium stearate; hypromellose; titanium dioxide; lactose; triacetin; silicon dioxide - dasatinib dr.reddy's is indicated for the treatment of adults aged 18 years or over with: ? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase. ? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib. ? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy. ? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib dr.reddy's is indicated for the treatment of paediatric patients with: ? ph+ cml in the chronic phase. ? newly diagnosed ph+ all in combination with chemotherapy.
hetero imatinib film coated tablets 100 mg
hetero singapore pte. ltd. - imatinib mesylate (form-α) eqv imatinib - tablet, film coated - imatinib mesylate (form-α) eqv imatinib 100.00mg
hetero imatinib film coated tablets 400 mg
hetero singapore pte. ltd. - imatinib mesylate (form-α) eqv imatinib - tablet, film coated - imatinib mesylate (form-α) eqv imatinib 400.00mg
mubucho 111 mg film-coated tablets
zentiva k.s. - dasatinib - film-coated tablet - dasatinib
mubucho 16 mg film-coated tablets
zentiva k.s. - dasatinib - film-coated tablet - dasatinib
mubucho 40 mg film-coated tablets
zentiva k.s. - dasatinib - film-coated tablet - dasatinib
mubucho 55 mg film-coated tablets
zentiva k.s. - dasatinib - film-coated tablet - dasatinib
mubucho 63 mg film-coated tablets
zentiva k.s. - dasatinib - film-coated tablet - dasatinib
mubucho 79 mg film-coated tablets
zentiva k.s. - dasatinib - film-coated tablet - dasatinib